Skip to main content
Clinical Trials/IRCT20200203046366N1
IRCT20200203046366N1
Completed
未知

Determination of therapeutic effect of tDCS in schizophrenic patients with predominant negative symptoms

Zanjan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Schizophrenia.
Sponsor
Zanjan University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • People diagnosed with schizophrenia on thebasis of DSM5
  • Patients receiving fixed antipsychotic treatment regimen for at least 4 weeks

Exclusion Criteria

  • 1\-substance dependency
  • comorbid psychiatric disorder(including suicidal individuals)
  • neurologic diseases such as epilepcy,CVA or cerebral vessels disease
  • physical disease such as malignancy,infections and heart failure, pragnancy, the existence of a metal implant in the body and skin disease involving scalp

Outcomes

Primary Outcomes

Not specified

Similar Trials